As per the article published in the journal mAntioxidants, hydrogen-enriched water (H2) reduces neuropathic pain syptoms and associated mental problems. Researchers from the Hospital de la Santa Creu i Sant Pau Research Institute (IIB Sant Pau) and the Universitat Autonoma de Barcelona have shown this in animal models.
7-10% and 20% of Spanish suffer from neuropathic and chronic pain respectively
Seven to ten percent of the Spanish population suffers from neuropathic pain. And, twenty per cent of the Spanish population suffers from chronic pain. This condition is mostly caused by nerve damage which causes people to feel intense and constant pain. But, treatments for these are scarce and often involve a large number of adverse effects.
For this reason, the Molecular Neuropharmacology research group, is looking for new therapeutic possibilities that can help people who suffer from it. This research is coordinated by Olga Pol at the Sant Pau Biomedical Research Institute and the UAB Institute of Neurosciences.
They have analyzed the effects of administering to mice models of neuropathic pain water enriched with hydrogen molecules in a study. This is a treatment that had already shown positive effects in neurological disorders, such as Alzheimer’s disease and depression.
This is a very promising treatment of neuropathic pain and associated emotional disorders
Due to its analgesic and anti- inflammatory effects as well as its anxiolytic and antidepressant properties, the results point to this strategy as a very promising candidate for the treatment of neuropathic pain and associated emotional disorders. also read:-Medications are already available with new drug offers for common kidney disease
Olga Pol explains “This treatment can alleviate not only the pain caused by a nerve injury, but also the states of anxiety and depression that accompany it. which would substantially improve the patients’ quality of life. This is important because it can allow a more effective and global treatment of neuropathic pain with fewer side effects”.
It will be investigated how the treatment works in animal models
The treatment was administered to mice by injection in the study. But, in the future other routes will be tested, such as oral administration. The next steps will be to investigate how the treatment works in animal models of pain associated with chemotherapy. This is because many times cancer patients present neuropathic pain as a side effect of the treatment. And, also evaluating its effects on the memory and emotional deficits that can also be suffered by same patients.